• Skip to main content
  • Skip to primary sidebar
virology blog

virology blog

About viruses and viral disease

Porcine circovirus DNA found in RotaTeq

7 May 2010 by Vincent Racaniello

The US Food and Drug Administration recently recommended that administration of Glaxo SmithKline’s Rotarix vaccine, which protects against rotavirus infection, be suspended after an independent research group found that the vaccine contains DNA of porcine circovirus type 1. Now the FDA reports finding circovirus DNA in the rotavirus vaccine made by Merck:

FDA recently received information from Merck & Co, Inc. that its preliminary studies have identified fragments of DNA from PCV1 and from a related porcine circovirus type 2 (PCV2) in its RotaTeq vaccine. Merck’s findings suggest that the number of PCV DNA fragments in its vaccine may be smaller than what has been found in Rotarix.

FDA has so far not recommended suspension of RotaTeq use. The Vaccines and Related Biological Products Advisory Committee meets today, after which FDA will make further recommendations on the use of the licensed rotavirus vaccines in the United States.

The source of porcine circovirus type 1 DNA in both Rotarix and RotaTeq is likely to be trypsin used during propagation of the cell cultures necessary for vaccine production. The enzyme is produced from porcine pancreas.

Update 10 May 2010: The FDA has posted a briefing document for the VRBPAC meeting that was held this past Friday. The Los Angeles Times reports on the outcome of the meeting:

Members of a Food and Drug Administration advisory committee meeting Friday urged physicians to continue using both commercial rotavirus vaccines despite evidence that both carry trace contaminants from a harmless pig virus. The panel did not take a formal vote on a recommendation, but a majority of participants said they thought the benefits of the vaccine far outweigh any potential risk. An agency spokeswoman said it would make no immediate recommendation on the vaccines, but would act expeditiously to come to a decision.

Finally, there are some good quotations from committee members in the article at Medscape Today.

Filed Under: Information Tagged With: porcine circovirus, rotarix, rotateq, rotavirus, trypsin, viral, virology, virus

Reader Interactions

Comments

  1. natasa778 says

    9 May 2010 at 9:57 am

    Few questions regarding trypsin, the suspected source of contamination: is it usually produced in-house by vaccine manufacturers or bought from external suppliers? If yes, are there many different ones?

    How widely is trypsin used in production of biologicals? Should we be checking other products that are manufactured using trypsin?

  2. profvrr says

    9 May 2010 at 1:10 pm

    Trypsin for cell culture is usually purchased from suppliers, and
    there are many. Any biological that is produced in cell culture could
    contain porcine circovirus 1 from the trypsin used. The alternative
    would be to use non-enzymatic methods for dissociating cells, which
    would avoid the trypsin.

  3. jillba says

    9 May 2010 at 8:11 pm

    I see that trypsin is used in baby food to help babies digest is better. Is it possible that porcine circovirus can be in this as well? Thank you.

  4. jillba says

    9 May 2010 at 9:54 pm

    Nevermind. One of my friends told me that since it is cooked, the virus will be destroyed. You have to admit, this can not be kosher.

  5. profvrr says

    10 May 2010 at 2:16 am

    It's not kosher in any sense of the word to have viral contaminants!
    Pork or otherwise, if you understand my meaning.

  6. profvrr says

    11 May 2010 at 10:18 pm

    Grant, I replied on the sciblog site you linked to, but it's not appearing.

  7. Grant says

    12 May 2010 at 11:36 am

    Thanks for that. I see it has now turned up on his blog, rather than at sciblogs. (It's confusing how his commenting is set up!)

    FWIW, I generalised my earlier comment at sciblogs. Most readers there are media and public, not scientists and I didn't want to make the argument too fiddly. (Ifs and buts look bad, etc.) I'm never sure if this is right way to go about it, but there you go.

    I saw your earlier post before I wrote to you. It's very interesting and I was (am?) tempted to blog about it myself. I'd be curious on your opinion if for the general public it helps to separate the “evolutionary time scale” events from shorter-term “public health risk level” events? (Even though with viruses this isn't entirely possible.)

Primary Sidebar

by Vincent Racaniello

Earth’s virology Professor
Questions? virology@virology.ws

With David Tuller and
Gertrud U. Rey

Follow

Facebook, Twitter, YouTube, Instagram
Get updates by RSS or Email

Contents

Table of Contents
ME/CFS
Inside a BSL-4
The Wall of Polio
Microbe Art
Interviews With Virologists

Earth’s Virology Course

Virology Live
Columbia U
Virologia en Español
Virology 101
Influenza 101

Podcasts

This Week in Virology
This Week in Microbiology
This Week in Parasitism
This Week in Evolution
Immune
This Week in Neuroscience
All at MicrobeTV

Useful Resources

Lecturio Online Courses
HealthMap
Polio eradication
Promed-Mail
Small Things Considered
ViralZone
Virus Particle Explorer
The Living River
Parasites Without Borders

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.